SK803a : Skin basal cell carcinoma tissue array with benign nevus tissue as control, including TNM, stage and pathology grade, 50 cases/ 100 cores
|
Microarray Panel | Skin basal cell carcinoma tissue microarray with benign nevus tissue, containing 30 cases of basal cell carcinoma, 20 cases of benign nevus, duplicate cores per case | |
Cores | 100 | |
Cases | 50 | |
Row number | 10 | |
Column number | 10 | |
Core Diameter (mm) | 1 | |
Thickness (µm) | 5 | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Bre - Breast,
Ear - Ear,
Fib - Fibrous tissue,
Par - Parotid gland,
Ski - Skin,
Vul - Vulva - Benign tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIB), - Malignant tumor (stage IVA), - Normal tissue |
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 57 | M | Skin | Multifocal superficial basal cell carcinoma of scalp (sparse) | T2bN0M0 | II | Malignant | ||
A2 | 2 | 57 | M | Skin | Multifocal superficial basal cell carcinoma of scalp | T2bN0M0 | II | Malignant | ||
A3 | 3 | 61 | M | Skin | Nodular basal cell carcinoma of left face | T2N0M0 | II | Malignant | ||
A4 | 4 | 61 | M | Skin | Nodular basal cell carcinoma of left face | T2N0M0 | II | Malignant | ||
A5 | 5 | 53 | M | Skin | Morpheic basal cell carcinoma of scalp | T1N0M0 | I | Malignant | ||
A6 | 6 | 53 | M | Skin | Morpheic basal cell carcinoma of scalp | T1N0M0 | I | Malignant | ||
A7 | 7 | 61 | M | Skin | Keratatic basal cell carcinoma of left face | T2N0M0 | II | Malignant | ||
A8 | 8 | 61 | M | Skin | Keratatic basal cell carcinoma of left face | T2N0M0 | II | Malignant | ||
A9 | 9 | 75 | M | Fibrous tissue | Nodular basal cell carcinoma of right groin | T1N0M0 | I | Malignant | ||
A10 | 10 | 75 | M | Fibrous tissue | Nodular basal cell carcinoma of right groin | T1N0M0 | I | Malignant | ||
B1 | 11 | 60 | M | Skin | Keratatic basal cell carcinoma of left face | T1N0M0 | I | Malignant | ||
B2 | 12 | 60 | M | Skin | Keratatic basal cell carcinoma of left face | T1N0M0 | I | Malignant | ||
B3 | 13 | 75 | F | Skin | Morpheic basal cell carcinoma of right ear | T2N1M0 | III | Malignant | ||
B4 | 14 | 75 | F | Skin | Morpheic basal cell carcinoma of right ear | T2N1M0 | III | Malignant | ||
B5 | 15 | 50 | F | Breast | Nodular basal cell carcinoma of left nipple | T4N0M0 | IIIB | Malignant | ||
B6 | 16 | 50 | F | Breast | Nodular basal cell carcinoma of left nipple | T4N0M0 | IIIB | Malignant | ||
B7 | 17 | 80 | F | Skin | Pigmented basal cell carcinoma of scalp | T1N0M0 | I | Malignant | ||
B8 | 18 | 80 | F | Skin | Pigmented basal cell carcinoma of scalp | T1N0M0 | I | Malignant | ||
B9 | 19 | 65 | F | Parotid gland | Basal cell adenocarcinoma | T3N1M0 | IVA | Malignant | ||
B10 | 20 | 65 | F | Parotid gland | Basal cell adenocarcinoma | T3N1M0 | IVA | Malignant | ||
C1 | 21 | 60 | F | Vulva | Pigmented basal cell carcinoma of left labia majora | T4N0M0 | III | Malignant | ||
C2 | 22 | 60 | F | Vulva | Pigmented basal cell carcinoma of left labia majora | T4N0M0 | III | Malignant | ||
C3 | 23 | 70 | F | Vulva | Fibroepithelial basal cell carcinoma of mons pubis | T4N0M0 | III | Malignant | ||
C4 | 24 | 70 | F | Vulva | Fibroepithelial basal cell carcinoma of mons pubis | T4N0M0 | III | Malignant | ||
C5 | 25 | 64 | M | Skin | Basosquamous basal cell carcinoma of scalp | T2N0M0 | II | Malignant | ||
C6 | 26 | 64 | M | Skin | Basosquamous basal cell carcinoma of scalp | T2N0M0 | II | Malignant | ||
C7 | 27 | 63 | F | Skin | Basal cell carcinoma with adnexal differentiation of right neck | T2N0M0 | II | Malignant | ||
C8 | 28 | 63 | F | Skin | Basal cell carcinoma with adnexal differentiation of right neck | T2N0M0 | II | Malignant | ||
C9 | 29 | 62 | M | Skin | Nodular basal cell carcinoma of right temporal | T4N0M0 | III | Malignant | ||
C10 | 30 | 62 | M | Skin | Nodular basal cell carcinoma of right temporal | T4N0M0 | III | Malignant | ||
D1 | 31 | 62 | M | Skin | Keratatic basal cell carcinoma of left chest | T2N0M0 | II | Malignant | ||
D2 | 32 | 62 | M | Skin | Keratatic basal cell carcinoma of left chest | T2N0M0 | II | Malignant | ||
D3 | 33 | 74 | F | Skin | Nodular basal cell carcinoma of right frontal | T2N0M0 | II | Malignant | ||
D4 | 34 | 74 | F | Skin | Nodular basal cell carcinoma of right frontal | T2N0M0 | II | Malignant | ||
D5 | 35 | 58 | M | Skin | Basal cell carcinoma with adnexal differentiation of back | T1N0M0 | I | Malignant | ||
D6 | 36 | 58 | M | Skin | Basal cell carcinoma with adnexal differentiation of back | T1N0M0 | I | Malignant | ||
D7 | 37 | 70 | M | Skin | Nodular basal cell carcinoma of right back | T2N0M0 | II | Malignant | ||
D8 | 38 | 70 | M | Skin | Nodular basal cell carcinoma of right back | T2N0M0 | II | Malignant | ||
D9 | 39 | 55 | M | Skin | Nodular basal cell carcinoma of scalp | T2N0M0 | II | Malignant | ||
D10 | 40 | 55 | M | Skin | Nodular basal cell carcinoma of scalp | T2N0M0 | II | Malignant | ||
E1 | 41 | 85 | F | Skin | Nodular basal cell carcinoma of nose | T2N0M0 | II | Malignant | ||
E2 | 42 | 85 | F | Skin | Nodular basal cell carcinoma of nose | T2N0M0 | II | Malignant | ||
E3 | 43 | 82 | M | Skin | Nodular basal cell carcinoma of right oxter | T3N0M0 | II | Malignant | ||
E4 | 44 | 82 | M | Skin | Nodular basal cell carcinoma of right oxter | T3N0M0 | II | Malignant | ||
E5 | 45 | 84 | F | Skin | Basal cell carcinoma with adnexal differentiation of right neck | T2N0M0 | II | Malignant | ||
E6 | 46 | 84 | F | Skin | Basal cell carcinoma with adnexal differentiation of right neck | T2N0M0 | II | Malignant | ||
E7 | 47 | 47 | F | Skin | Morpheic basal cell carcinoma of tempus | T1N0M0 | I | Malignant | ||
E8 | 48 | 47 | F | Skin | Morpheic basal cell carcinoma of tempus (skeletal muscle tissue) | T1N0M0 | I | Malignant | ||
E9 | 49 | 80 | M | Skin | Pigmented basal cell carcinoma of left leg | T1N0M0 | I | Malignant | ||
E10 | 50 | 80 | M | Skin | Pigmented basal cell carcinoma of left leg | T1N0M0 | I | Malignant | ||
F1 | 51 | 75 | M | Skin | Pigmented basal cell carcinoma of occipital | T2N0M0 | II | Malignant | ||
F2 | 52 | 75 | M | Skin | Pigmented basal cell carcinoma of occipital | T2N0M0 | II | Malignant | ||
F3 | 53 | 54 | F | Skin | Nodular basal cell carcinoma of scalp | T2N0M0 | II | Malignant | ||
F4 | 54 | 54 | F | Skin | Nodular basal cell carcinoma of scalp | T2N0M0 | II | Malignant | ||
F5 | 55 | 82 | F | Skin | Keratatic basal cell carcinoma of frontal | T1N0M0 | I | Malignant | ||
F6 | 56 | 82 | F | Skin | Keratatic basal cell carcinoma of frontal | T1N0M0 | I | Malignant | ||
F7 | 57 | 36 | M | Ear | Nodular basal cell carcinoma of right ear | T1N0M0 | I | Malignant | ||
F8 | 58 | 36 | M | Ear | Nodular basal cell carcinoma of right ear (sparse) | T1N0M0 | I | Malignant | ||
F9 | 59 | 62 | F | Skin | Basal cell carcinoma with adnexal differentiation of right face (sparse) | T1N0M0 | I | Malignant | ||
F10 | 60 | 62 | F | Skin | Basal cell carcinoma with adnexal differentiation of right face | T1N0M0 | I | Malignant | ||
G1 | 61 | 30 | F | Skin | Intradermal nevus of right buttock | - | - | Benign | ||
G2 | 62 | 30 | F | Skin | Intradermal nevus of right buttock | - | - | Benign | ||
G3 | 63 | 50 | M | Skin | Compound nevus of upper arm | - | - | Benign | ||
G4 | 64 | 50 | M | Skin | Compound nevus of upper arm | - | - | Benign | ||
G5 | 65 | 29 | F | Skin | Compound nevus of left shoulder | - | - | Benign | ||
G6 | 66 | 29 | F | Skin | Compound nevus of left shoulder | - | - | Benign | ||
G7 | 67 | 35 | M | Skin | Sebaceous nevus of right tempus | - | - | Benign | ||
G8 | 68 | 35 | M | Skin | Sebaceous nevus of right tempus | - | - | Benign | ||
G9 | 69 | 35 | F | Skin | Intradermal nevus of chest wall | - | - | Benign | ||
G10 | 70 | 35 | F | Skin | Intradermal nevus of chest wall | - | - | Benign | ||
H1 | 71 | 23 | F | Skin | Compound nevus of right waist (appendix tissue) | - | - | Benign | ||
H2 | 72 | 23 | F | Skin | Compound nevus of right waist (appendix tissue) | - | - | Benign | ||
H3 | 73 | 25 | M | Skin | Compound nevus of left leg | - | - | Benign | ||
H4 | 74 | 25 | M | Skin | Compound nevus of left leg | - | - | Benign | ||
H5 | 75 | 20 | M | Skin | Intradermal nevus of left shoulder | - | - | Benign | ||
H6 | 76 | 20 | M | Skin | Intradermal nevus of left shoulder | - | - | Benign | ||
H7 | 77 | 38 | M | Skin | Intradermal nevus of right face | - | - | Benign | ||
H8 | 78 | 38 | M | Skin | Intradermal nevus of right face | - | - | Benign | ||
H9 | 79 | 62 | M | Skin | Junction nevus of chest wall | - | - | Benign | ||
H10 | 80 | 62 | M | Skin | Junction nevus of chest wall | - | - | Benign | ||
I1 | 81 | 10 | F | Skin | Compound nevus of right foot | - | - | Benign | ||
I2 | 82 | 10 | F | Skin | Compound nevus of right foot | - | - | Benign | ||
I3 | 83 | 34 | F | Skin | Sebaceous nevus of head | - | - | Benign | ||
I4 | 84 | 34 | F | Skin | Sebaceous nevus of head | - | - | Benign | ||
I5 | 85 | 2 | F | Skin | Intradermal nevus of face | - | - | Benign | ||
I6 | 86 | 2 | F | Skin | Intradermal nevus of face | - | - | Benign | ||
I7 | 87 | 32 | M | Skin | Sebaceous nevus of right elbow | - | - | Benign | ||
I8 | 88 | 32 | M | Skin | Sebaceous nevus of right elbow | - | - | Benign | ||
I9 | 89 | 6 Mon. | M | Skin | Intradermal nevus of face | - | - | Benign | ||
I10 | 90 | 6 Mon. | M | Skin | Intradermal nevus of face | - | - | Benign | ||
J1 | 91 | 39 | M | Skin | Compound nevus of scalp | - | - | Benign | ||
J2 | 92 | 39 | M | Skin | Compound nevus of scalp | - | - | Benign | ||
J3 | 93 | 11 | M | Skin | Pigmented intradermal nevus | - | - | Benign | ||
J4 | 94 | 11 | M | Skin | Pigmented intradermal nevus | - | - | Benign | ||
J5 | 95 | 2 | F | Skin | Intradermal nevus of right leg | - | - | Benign | ||
J6 | 96 | 2 | F | Skin | Intradermal nevus of right leg | - | - | Benign | ||
J7 | 97 | 50 | M | Skin | Skin tissue | - | - | Normal | ||
J8 | 98 | 50 | M | Skin | Skin tissue | - | - | Normal | ||
J9 | 99 | 2 Mon. | M | Skin | Skin tissue of head | - | - | Normal | ||
J10 | 100 | 2 Mon. | M | Skin | Skin tissue of head | - | - | Normal | ||
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: SK803a
- Availability: In Stock